Dihydronaphthalene derivative
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Oct 18, 2022
Grant Date -
N/A
app pub date -
Dec 3, 2015
filing date -
Dec 4, 2014
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
A compound represented by general formula (I) wherein all the symbols are as defined in the specification has a selective S1P5 receptor agonist activity due to having a linker from a phenyl group to a cyclic substituent in a dihydronaphthalene skeleton; i.e., due to having a short linker of one atom or less as L in general formula (I), and can therefore serve as an agent for treating S1P5-mediated disease, e. g., neurodegenerative disease such as schizophrenia.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully